According to our report, the size of the Global Anatomic Pathology Market value predicted to worth USD 19.4 billion in 2019 and is estimated to be growing at a CAGR of 6.16%, to reach USD 26.1 billion by 2024.
What is anatomic pathology?
Anatomic Pathology is a branch of pathology which can be defined as a specialization of medicine, in which the diagnosis of the disease is carried out by examining tissues and organs at a microscopic, biochemical, immunological, and macroscopic levels. The key function of anatomy pathology is to detect abnormalities that can be helpful to enhance diagnostics and treatment management. Anatomy pathology is most frequently applied to detect different types of tumors and cancers, liver and kidney diseases, infections, and autoimmune disorders. The lines are blurring between the clinical pathology and anatomical pathology owing to the technological advancements leading to the overlapping of both the branches, the procedures like flow cytometry, molecular pathology, cytogenetics can be performed on both fluid samples and tissue samples.
Rising the aging population across the world is certainly a major factor bolstering the demand for the anatomic pathology market. Also, increasing incidences of chronic diseases due to changes in food habits and lifestyle is accelerating the growth of the market. Additionally, the market is propelled by increasing demand to improve the diagnostic procedures in every clinical center.
However, lack of standardization is slowly hampering the demand of the market. Stringent rules and regulations by the government are also impacting negatively on the growth of the Anatomic Pathology Market.
Increasing concern towards health and also a priority for early diagnosis are setting up growth opportunities for the anatomic pathology market. Rise in the disposable income in urban areas is lavishing the demand of the market to the extent. The adoption of the latest technologies and also the launch of innovative techniques in the medical sector is magnifying the growth of the Anatomic Pathology Market further.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Product Type, End-User, Application, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Agilent Technologies, Danaher Corporation, Sakura Fine technical Co. Ltd., Metropolis, IBISWorld’s Pathology Services |
In this research report, the Global Anatomic Pathology Market has been segmented and sub-segmented into the following categories and calculated the market size and forecast for each segment until 2024.
Anatomic Pathology Market Analysis - By Product
On the basis of product type, Instruments type is leading with the highest shares of the market. Changes in lifestyles and food habits are escalating the growth of the market to the extent. Rise in the incidences of various health disorders is another factor propelling the demand of the anatomic pathology market. In addition, increasing expenditure on healthcare is elevating the growth of the anatomic pathology market. In the medical sector, there is a growing need to improve the diagnostic procedures and also to analyze the issue with a clear vision so as to promote effective treatment for the patient is greatly influencing the demand of the market.
Anatomic Pathology Market Analysis - By End-User
On the basis of the end-user, the diagnostics lab segment is contributing the highest shares for the market. Increasing support from both private and public organizations in healthcare centers is accelerating the demand of the market. Growing awareness over the availability of various diagnostic procedures for many health disorders is likely to outshine the demand of the market. The rise in the number of research institutes in the medical sector is lavishing the growth of the anatomic pathology market.
Anatomic Pathology Market Analysis - By Application
Lymphoma application is witnessed in holding prominent shares of the market with the adoption of the latest technology in diagnosing and treating the disease. Increasing disposable income especially in urban areas is also one of the factors fueling the growth of the market. The growing tendency to launch innovative devices in favor of the end-users is ascribed to bolster the demand of the market. Rise in the revenue in developed and developing countries is also to magnify the significant growth rate of the anatomic pathology market.
Regional Analysis
North America is accounted for holding the highest shares of the market. Rise in the awareness over the diagnosis procedures is driving the growth of the industry. In addition, the growing number of research institutes to improve the performance is boosting up the demand of the market.
The Asia Pacific is following North America in holding the largest shares of the market. The growing geriatric population is one of the factors outshining the demand of the business. Also, increasing the construction of hospitals with the latest equipment is broadening the growth of this market.
Europe witnessed the fastest growth rate from the past few years and it is deemed to have a significant growth rate in the coming years. Acceptance of the latest technologies and implementation of new devices at a high success rate are escalating the demand of the Anatomic Pathology Market. The Middle East and Africa are expected to have slight variations in the growth rate in the near future.
Top companies in the Global Anatomic Pathology Market profiled in this report are
Recent developments in this industry:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.3 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 End-User
5.2.1 Introduction
5.2.2 Diagnostics Lab
5.2.3 Hospitals
5.2.4 Physicians' Office Lab
5.2.5 Y-o-Y Growth Analysis, By End-User
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By End-User
5.3 Application
5.3.1 Introduction
5.3.2 Lymphoma
5.3.3 Breast
5.3.4 Lung
5.3.5 Cervical
5.3.6 Colorectal
5.3.7 Prostate
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End-User
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End-User
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End-User
6.1.5.4 By Application
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 F. Hoffmann-La Roche AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 NeoGenomics Laboratories Inc.
8.3 Laboratory Corporation of America Holdings
8.4 Thermo Fisher Scientific
8.5 Quest Diagnostics Incorporated
8.6 Agilent Technologies
8.7 Danaher Corporation
8.8 Sakura Finetechnical Co. Ltd.
8.9 Metropolis
8.10 IBISWorld’s Pathology Services
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
